Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M202065200 on April 12, 2002

J. Biol. Chem., Vol. 277, Issue 26, 23684-23692, June 28, 2002
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
277/26/23684    most recent
M202065200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mogensen, J. E.
Right arrow Articles by Otzen, D. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mogensen, J. E.
Right arrow Articles by Otzen, D. E.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

The Major Birch Allergen, Bet v 1, Shows Affinity for a Broad Spectrum of Physiological Ligands*

Jesper E. MogensenDagger , Reinhard WimmerDagger , Jørgen N. Larsen§, Michael D. Spangfort§, and Daniel E. OtzenDagger

From the Dagger  Department of Biotechnology, Institute of Life Sciences, Aalborg University, Sohngaardsholmsvej 49, Aalborg DK-9000 and the § Biochemical Allergy Research, ALK-Abelló A/S, Bøge Allé 6-8, Hørsholm DK-2970, Denmark

Received for publication, March 1, 2002, and in revised form, April 9, 2002

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Bet v 1 is a 17-kDa protein abundantly present in the pollen of the White birch tree and is the primary cause of birch pollen allergy in humans. Its three-dimensional structure is remarkable in that a solvent-accessible cavity traverses the core of the molecule. The biological function of Bet v 1 is unknown, although it is homologous to a family of pathogenesis-related proteins in plants. In this study we first show that Bet v 1 in the native state is able to bind the fluorescent probe 8-anilino-1-naphthalenesulfonic acid (ANS). ANS binds to Bet v 1 with 1:1 stoichiometry, and NMR data indicate that binding takes place in the cavity. Using an ANS displacement assay, we then identify a range of physiologically relevant ligands, including fatty acids, flavonoids, and cytokinins, which generally bind with low micromolar affinity. The ability of these ligands to displace ANS suggests that they also bind in the cavity, although the exact binding sites seem to vary among different ligands. The cytokinins, for example, seem to bind at a separate site close to ANS, because they increase the fluorescence of the ANS·Bet v 1 complex. Also, the fluorescent sterol dehydroergosterol binds to Bet v 1 as demonstrated by direct titrations. This study provides the first qualitative and quantitative data on the ligand binding properties of this important pollen allergen. Our findings indicate that ligand binding is important for the biological function of Bet v 1.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Bet v 11 is a 17-kDa protein constituting 10% (w/w) of the protein fraction in aqueous extracts of mature pollen from the White birch tree (Betula verrucosa). It shows a considerable degree of heterogeneity when analyzed by two-dimensional gel electrophoresis and immunoblotting using rabbit antiserum raised against purified Bet v 1, because pollen from a single birch tree exhibits between 5 and 10 spots, whereas a pollen extract reveals 24 spots (1). Approximately 50 isoforms have been cloned and sequenced, displaying a primary amino acid sequence identity in the range of 99-72%. Both the solution and crystal structure of Bet v 1 have been determined (2). The main feature of the structure is a seven-stranded anti-parallel beta -sheet that wraps around a 25-residue-long C-terminal alpha -helix. The beta -sheet and the C-terminal part of the long helix are separated by two small consecutive helices. A most unusual feature of the structure is a large forked solvent-accessible cavity penetrating the core of the molecule (2). Moreover, the structure of Bet v 1 contains a P-loop motif, a structural element found in nucleotide binding proteins, where it is responsible for binding nucleotides (3).

Bet v 1 is a major cause of tree pollen allergy in humans (4) affecting an estimated 100 million people worldwide (5). Despite the immunological interest in Bet v 1, little is known about its biological function. It is homologous to a group of pathogenesis-related proteins, the PR-10 proteins, that are expressed during disease and in stress situations (6) and that seem to be ubiquitous in plants (7). The closest relatives are found in the pollens of the related trees alder (8), hornbeam (9), and hazel (10), and birch pollen-allergic individuals often cross-react to the pollens of these species. Bet v 1 homologues present in various fruits and vegetables, particularly apple (11), but also in cherry (12) and celery (13), cause the oral allergy syndrome upon oral ingestion in some birch pollen-allergic patients (14). The identity percentages to these homologues are in the range of 65-56%. Several more distantly related PR-10 proteins from a variety of plant species have been described. These proteins are not serologically cross-reactive, and homology percentages range between 54 and 33%. In addition, homology between the PR-10 proteins and a group of proteins termed the major latex proteins (15), including members from opium poppy (16) and bell pepper (17), has been described. Finally, Bet v 1 shows remarkable structural similarity to the 200-amino acid START domain of MLN64 (18), a protein involved in the mobilization of cholesterol in human placenta and brain (19), although there is no sequence homology.

Little experimental data exist on the functional properties of the numerous Bet v 1 homologues, yet some activities have been reported. The START domain of MLN64 is capable of binding one molecule of cholesterol (18). The PR-10 member from mung bean is a cytokinin-specific binding protein capable of binding cytokinins and cytokinin analogues with nanomolar affinity (20). Very recently, the major allergen from cherry, Pru av 1, whose backbone folding pattern is very similar to that of Bet v 1, was reported to bind the phytosteroid homocastasterone (21). Furthermore, PR-10 members from ginseng (22) and white lupin (23) as well as Bet v 1 (24, 25) have been reported to show RNase activity. It thus appears that PR-10 proteins display enzymatic activity as well as ligand binding activity, which is also reflected in the classification of the START domain superfamily, including both START domain proteins and PR-10 proteins among others (26). We show here that Bet v 1 is able to bind a wide range of both synthetic and naturally occurring compounds with moderate to high affinity and discuss the implications of the identified ligands for a possible biological function of Bet v 1.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Chemicals

Lauric acid, stearic acid, and oleic acid were from Fluka (Busch, Germany); deuterium oxide, deuterated HCl, deuterated ethanol, and deuterated phosphate buffer were from Cambridge Isotope Laboratories (Andover, MA). All other chemicals were from Sigma Chemical Co. (St. Louis, MO). All chemicals were of analytical or biological grade. Bet v 1.2801 was produced and purified as described previously (27). The protein concentration was determined spectrophotometrically using a molar extinction coefficient of 9735 M-1 cm-1 at 280 nm as determined by the method of Gill and von Hippel (28).

Data Analysis and Inner Filter Effect Corrections

Non-linear least squares regression analysis was carried out with the program Kaleidagraph, version 3.5 (Synergy Software, Reading, PA). Unless stated otherwise, the error mentioned throughout the text is the standard error of the mean. Where necessary, we corrected for inner filter effects using the equation (29),
&kgr;=<FR><NU><UP>ln</UP>(10)<UP>·</UP>&agr;<UP>·</UP>&dgr;</NU><DE>10<SUP>−&agr; · <FENCE><FR><NU>d</NU><DE>2</DE></FR>−<FR><NU>&dgr;</NU><DE>2</DE></FR></FENCE></SUP>−10<SUP>−&agr; · <FENCE><FR><NU>d</NU><DE>2</DE></FR>+<FR><NU>&dgr;</NU><DE>2</DE></FR></FENCE></SUP></DE></FR> (Eq. 1)
where kappa  is the inner filter effect correction factor, alpha  is the product of the molar extinction coefficient and the concentration, delta  is the emission slit width, and d is the cuvette path length. Cuvettes with low path lengths (3 mm) were used to reduce inner filter effects.

ANS·Bet v 1 Interaction

All fluorescence experiments were performed on an RTC2000 spectrometer from Photon Technology International (Lawrenceville, NJ) equipped with a 75-watt xenon arc lamp and a temperature control unit. Excitation and emission band paths were 5 nm. ANS was dissolved in 1 ml Me2SO and diluted to 100 ml with MilliQ water. The concentration was determined spectrophotometrically using a molar extinction coefficient of 4990 M-1 cm-1 at 350 nm in water (29). Excitation was performed at 350 nm corresponding to the maximum absorption wavelength.

Determination of Kd and Binding Stoichiometry-- The dissociation constant (Kd) was determined at 25 °C at pH 7 and pH 4 in 10 and 50 mM buffer, respectively, using an ANS concentration of 12 and 2 µM, respectively. The stoichiometry of binding was determined at pH 7 and pH 4 in 10 and 50 mM buffer, respectively, using ANS concentrations of 192 and 50 µM, respectively. Titrations with increasing Bet v 1 concentration were performed by preparing aliquots for each data point. The contribution of buffer and protein to the measured ANS fluorescence was subtracted. Data were fitted to the equation,


 F<SUB><UP>obs</UP></SUB>=F<SUB><UP>PL</UP></SUB>×<FR><NU><UP>−</UP>(K<SUB>d</SUB>+L<SUB>&Sgr;</SUB>+P<SUB>&Sgr;</SUB>)±<RAD><RCD>(K<SUB>d</SUB>+L<SUB>&Sgr;</SUB>+P<SUB>&Sgr;</SUB>)<SUP>2</SUP>−4 · L<SUB>&Sgr;</SUB> · P<SUB>&Sgr;</SUB></RCD></RAD></NU><DE><UP>−</UP>2<UP>·</UP>L<SUB>&Sgr;</SUB></DE></FR> (Eq. 2)
where Fobs is the observed fluorescence, FPL is the fluorescence of the protein·ligand complex at saturation, Kd is the dissociation constant, L∑ is the total ligand concentration, and P∑ is the total protein concentration. FPL and Kd are fitted as free parameters by non-linear least squares regression analysis. Equation 2 is derived from a simple ligand binding model assuming that the observed fluorescence is due solely to bound ANS. This is a reasonable assumption, because the fluorescence emission intensity of ANS increases around 50-fold upon binding to Bet v 1 (see "Results"). The stoichiometry of binding was determined in a plot of ANS fluorescence as a function of [Bet v 1]/[ANS]. The value of the independent parameter corresponding to the break point of the curve indicates the number of protein molecules bound per ANS molecule. Due to the high ANS concentration used in these experiments the observed ANS fluorescence is corrected by a constant value calculated from Equation 1.

pH Profile of ANS in Complex with Bet v 1-- At 20 and 200 µM, respectively, ANS was incubated with 2.5 µM Bet v 1 in 50 mM buffer, and the fluorescence of ANS and of Bet v 1 was recorded for each sample at 25 °C. Far-UV CD spectra of 10 µM Bet v 1 as a function of pH were recorded on a JASCO J-715 spectropolarimeter (Jasco Spectroscopic Co. Ltd., Hachioji City, Japan). The buffers used were as follows: pH 1, 0.1 M HCl; pH 2-3.5, glycine; pH 3.7-4.7, sodium acetate; pH 6, MES; pH 7, MOPS; pH 8-9, Tris; pH 10-11, glycine; pH 13, 0.1 M NaOH. The contributions of buffer and protein to the measured ANS fluorescence and of buffer to the measured ellipticity were subtracted. The use of "Good" buffers (29) had no effect on ANS binding to Bet v 1 (data not shown).

Identification of the ANS Binding Site by NMR Spectroscopy-- NMR experiments were recorded on a Bruker DRX600 spectrometer equipped with a 5-mm xyz-grad TXI(H/C/N) probe. Initially, a NOESY spectrum of 1.45 mM Bet v 1 in 95%/5% (v/v) 1H2O/2H2O in phosphate-buffered saline was recorded. ANS was then added to a final concentration of 1.4 mM, and a new NOESY spectrum was recorded. Additionally, a sample in pure 2H2O was employed. To facilitate exchange, Bet v 1 was unfolded by lowering the pH to 2.1, where unfolding is most extensive (data not shown), with deuterated HCl. After 20 h, pH was brought back to 7, and 2H2O was exchanged with 10 mM deuterated phosphate buffer, pH 7, by use of a Millipore (Bedford, MA) Centricon YM-10 centrifugation cell. The final Bet v 1 concentration was 850 µM. After acquisition of a NOESY spectrum, ANS dissolved in deuterated ethanol was added to a final concentration of 790 µM and a new NOESY spectrum was recorded. All NMR experiments were performed at 298 K. The free induction decays in the direct dimension were collected with 4096 points at 1.61 Hz/point resolution and in the indirect dimension with 1024 points at 6.45 Hz/point resolution. The maximum t1 value was 77.4 ms, and the maximum t2 was 309.7 ms. A Gaussian window function was used in both dimensions. Quadrature detection in the indirect dimension was achieved by the States-TPPI (time-proportional phase increment) protocol (30). The WATERGATE sequence was applied for water suppression (31). The NMR data were processed with the Bruker XWinNMR version 2.5 software, and spectral analysis was performed with XEASY version 1.3.13 (32). The assignments of Bet v 1 were obtained from the BioMagResBank, entry number 4417 (33); some aromatic side-chain assignments were obtained from Osmark (34). Peaks shifting in position upon addition of ANS were identified by comparing the NOESY spectra and assigned using the BBReader program (35).

Identification of Naturally Occurring Ligands

ANS Displacement Assay-- Typically, 10 µM Bet v 1 and 10 µM ANS in 50 mM phosphate, pH 7, at 25 °C was used in the ligand titration experiments. The concentrations of the Bet v 1 and ANS stock solutions were determined spectrophotometrically. ANS was excited at 350 nm. The contribution of buffer, Bet v 1, and ligand to the measured fluorescence was subtracted. Ligands with limited solubility in water were dissolved in absolute ethanol. The final ethanol concentration did not exceed 10% (v/v) ensuring that the decreased polarity of the solvent did not change the quantum yield of ANS (36). Far-UV CD spectra showed that, below 30% (v/v), the presence of ethanol in the samples had no denaturing effect on Bet v 1 (data not shown). bis-ANS was dissolved in 40 µl of Me2SO and diluted to 1 ml with MilliQ water. The concentration was determined spectrophotometrically using a molar extinction coefficient of 16,790 M-1 cm-1 at 385 nm in water (37). Excitation was performed at 383 nm corresponding to the maximum absorption wavelength.

Analysis of Displacement Data-- A simple rectangular hyperbolic binding model was employed to express the affinity of the ligand,


F<SUB><UP>obs</UP></SUB>=&Dgr;F×<FENCE>1−<FR><NU><UP>IC</UP><SUB>50</SUB></NU><DE><UP>IC</UP><SUB>50</SUB>+[L]</DE></FR></FENCE>+F<SUB><UP>baseline</UP></SUB> (Eq. 3)
where Fobs is the observed fluorescence, Delta F is the fluorescence change, Fbaseline is the fluorescence at saturation, and L denotes ligand. This model yields the parameter IC50, which is a crude measure of the Kd for the displacing ligand (38). IC50, Delta F, and Fbaseline are fitted as free parameters by non-linear least squares regression analysis. In a few instances direct titrations were also performed by monitoring the intrinsic fluorescence of the protein with excitation at 278 nm.

DHE·Bet v 1 Interaction-- Dehydroergosterol (DHE) was dissolved in absolute ethanol. The concentration of DHE was determined spectrophotometrically using an extinction coefficient of 10.550 M-1 cm-1 at 325 nm (39). 10 µM DHE was titrated with Bet v 1, and excitation was performed at 325 nm. The contribution of buffer to the measured DHE fluorescence was subtracted. The affinity of DHE for Bet v 1 was determined in the same manner as for ANS displacing ligands by use of Equation 3.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Bet v 1 Binds ANS in the Native State

The fluorescent probe ANS is traditionally used to detect molten globules, i.e. partly folded proteins that accumulate under mildly denaturing conditions. ANS is believed to bind to molten globules due to the presence of solvent-exposed hydrophobic patches, which are a particular characteristic of this protein state (40). Certain proteins also bind ANS in the native state, however, provided this conformation displays exposed hydrophobic sites (41-43). Because Bet v 1 contains a hydrophobic solvent-exposed cavity, we tested whether Bet v 1 in the native conformation is able to bind ANS specifically. Fluorescence emission spectra of ANS in the presence and absence of Bet v 1 are shown in Fig. 1. In water, ANS is essentially non-fluorescent and exhibits a maximum emission wavelength (lambda max) of ~515 nm. In the presence of Bet v 1 under native conditions (pH 7), ANS fluorescence displays a pronounced increase in intensity with a concomitant shift of lambda max to 474 nm, both of which indicate transfer of ANS to a less polar environment. These data show that Bet v 1 binds ANS in the native state.


View larger version (13K):
[in this window]
[in a new window]
 
Fig. 1.   ANS binds to native Bet v 1. Fluorescence of 3 µM ANS in the absence and presence of 1 µM Bet v 1 at 25 °C in 10 mM MOPS, pH 7. In the absence of Bet v 1, ANS fluorescence is very weak exhibiting a lambda max of ~515 nm (black-square). Upon addition of Bet v 1 the fluorescence of ANS increases with a concomitant shift of lambda max to 474 nm (). ANS was excited at 350 nm.

ANS Binding Is Characterized by Moderate Affinity and 1:1 Stoichiometry

The affinity of the interaction at pH 7 as well as pH 4 was examined by titration of ANS with Bet v 1 while following the ANS emission at 477 nm. The resulting binding curves, displayed in Fig. 2, show that ANS binds to Bet v 1 in a saturable manner. Fitting the raw data to Equation 2 yields Kd values of 18.5 ± 5.0 µM and 3.8 ± 0.3 µM at pH 7 and pH 4, respectively. Thus, binding is characterized by moderate affinity and is more favorable at low pH than at neutral pH, which is expected because ANS is negatively charged in the entire pH scale (29). A pH profile of 20 µM ANS mixed with 2.5 µM Bet v 1 (Fig. 3) corroborates the result of the titration experiments as ANS fluorescence peaks at pH 3.6 while still being significant at pH 7. Higher ANS concentrations were found to stabilize Bet v 1 by shifting the acid pH denaturation to lower values (data not shown). Thermal scans monitored by far-UV CD spectroscopy confirmed the stabilizing effect of ANS as Tm is raised from 45.3 ± 1.0 °C to 55.2 ± 0.5 °C when melting 10 µM Bet v 1 mixed with 100 µM ANS at pH 4 (data not shown). Fig. 3 also shows the unfolding profile of Bet v 1 as monitored by the intrinsic tyrosine fluorescence and far-UV CD spectroscopy. The two unfolding curves show that secondary and tertiary structure unfolds in parallel, which further supports the finding that ANS indeed binds to the native state of Bet v 1 and not to a partially unfolded state. Fig. 4 shows the titration of ANS with Bet v 1 at pH 7 under stoichiometric conditions. This experiment yields a binding stoichiometry of 0.9 ± 0.1, indicating that Bet v 1 possesses a specific binding site for ANS. The same experiment at pH 4 gives a stoichiometry of 1.1 ± 0.2 (data not shown). This finding supports the conclusion that higher affinity rather than an increase in the number of binding sites causes the increased ANS fluorescence at pH 4 compared with pH 7. 


View larger version (12K):
[in this window]
[in a new window]
 
Fig. 2.   Affinity of ANS·Bet v 1 interaction. Titration of A, 12 µM ANS in 10 mM MOPS, pH 7 and B, 2 µM ANS in 50 mM sodium acetate, pH 4, with Bet v 1 at 25 °C. The solid lines are the result of the best fit to Equation 2. Kd yields 18.5 ± 5.0 and 3.8 ± 0.3 µM at pH 7 and pH 4, respectively. ANS was excited at 350 nm; the emission at 477 nm is displayed.


View larger version (12K):
[in this window]
[in a new window]
 
Fig. 3.   pH profile of ANS in complex with Bet v 1. Fluorescence of 20 µM ANS () as a function of pH in 50 mM buffer in the presence of 2.5 µM Bet v 1 at 25 °C. ANS was excited at 350 nm; the emission at 477 nm is displayed. The contribution of ANS in buffer is subtracted. ANS fluorescence shows no intrinsic pH dependence (data not shown). The intrinsic fluorescence (open circle ) and molar ellipticity (black-triangle) of Bet v 1 as a function of pH are also shown. Bet v 1 was excited at 278 nm; the emission at 307 nm and molar ellipticity at 222 nm are displayed. The solid lines are drawn only to guide the eye.


View larger version (15K):
[in this window]
[in a new window]
 
Fig. 4.   Stoichiometry of the ANS·Bet v 1 interaction. Titration of 192 µM ANS with Bet v 1 under stoichiometric conditions at 25 °C in 10 mM MOPS, pH 7. The solid lines are drawn based on the initial linear increase in fluorescence and the maximum fluorescence at saturation. The dotted line is drawn vertically at the intercept of the two solid lines. The intercept of the dotted line with the abscissa gives the stoichiometry of the complex, which yields 0.9 ± 0.1 at pH 7. ANS was excited at 350 nm; the emission at 477 nm is displayed.

Two-dimensional NMR Data Show That Distinct Regions of the Protein Are Affected by ANS Binding

To identify the ANS binding site on the protein we compared two-dimensional NMR spectra of free and bound Bet v 1. Although the overall appearance of the Bet v 1 NOESY spectrum did not change after addition of ANS, numerous protons with a change in chemical shift of more than 0.02 ppm could be identified. These are summarized in Table I, whereas in Fig. 5 they are plotted on a molecular model of Bet v 1. One NOE could be found from a presumed ANS atom (8.33 ppm) to a protein atom at 0.75 ppm, presumably a methyl signal, but no assignment could be obtained. From a 2QF-COSY spectrum recorded in D2O, only three additional resonances were detected after addition of ANS (at 8.33, 7.32, and 7.82 ppm, where the proton at 7.32 ppm exhibits a cross peak to the two other protons). Looking at the distribution of the perturbed protein protons, they can be seen to form one large patch along the beta -sheet and several distinct regions in the alpha -helices (see Fig. 5). Very few perturbed protons can be detected on the outer surface of the protein. Although these data do not unequivocally pinpoint an ANS binding site, they do suggest that ANS binds in the cavity of Bet v 1. This is further corroborated by the two NOEs vanishing between Tyr-83 Hepsilon and Ile-102 Hgamma 1 and Hgamma 13, respectively. Fig. 5 shows the position of the side chains of these residues in the cavity. The broad swathe of perturbed atoms indicates either that there is no specific binding site for ANS within the cavity or that ANS binding causes some minor structural rearrangements in the protein molecule.

                              
View this table:
[in this window]
[in a new window]
 
Table I
Bet v 1 protons affected by ANS binding
Changes in chemical shift of Bet v 1 protons upon addition of ANS (Delta delta  = delta Bet v 1·ANS - delta Bet v 1). Considered only are atoms that could be assigned unambiguously with |Delta delta | > 0.02 ppm, which is well above the digital resolution of 1.6 Hz/point.


View larger version (35K):
[in this window]
[in a new window]
 
Fig. 5.   Bet v 1 protons affected by ANS binding. Stereo view of Bet v 1 showing the backbone folding pattern with secondary structural elements in gray. The pink spheres represent protons whose chemical shift is changed by more than 0.02 ppm when comparing NOESY spectra of Bet v 1 alone and in complex with ANS. The side chains of Tyr-83 and Ile-102 are represented by sticks in green. The NOEs disappearing upon addition of ANS are in blue. The image was prepared with MolMol, version 2.6 based on Protein Data Bank file 1bv1.

Binding of bis-ANS and SDS to Native Bet v 1

To test whether Bet v 1 can bind amphiphilic molecules in general, we also examined binding of bis-ANS and SDS. bis-ANS, which shows similar fluorescence characteristics as ANS, binds to Bet v 1 with high affinity, yielding a Kd of 53.6 ± 15.0 nM (data not shown). This is consistent with the observation that bis-ANS is superior to ANS as a probe of non-polar cavities in proteins, often binding with an affinity orders of magnitude higher (44). The titration experiment under stoichiometric conditions reveals a binding stoichiometry of 1:1 (data not shown). bis-ANS typically induces conformational changes on the secondary and tertiary level upon interaction with proteins (37, 45). This is also observed upon interaction with Bet v 1, because far-UV CD spectra reveal a slightly different content of secondary structure (data not shown). Bet v 1 was also found to bind SDS specifically. By following the intrinsic tyrosine fluorescence of the protein upon titration with SDS, the apparent dissociation constant (IC50 value determined from Equation 3) yields 28.2 ± 8.5 µM (Fig. 6). An indirect assay was also performed where a preformed complex between Bet v 1 and ANS was titrated with SDS. The decrease in ANS fluorescence as a function of SDS concentration shows that SDS is able to displace ANS (Fig. 6). The IC50 value obtained from Equation 3 yields 7.7 ± 0.6 µM, which suggests that there is a high affinity SDS binding site overlapping the ANS binding site in addition to the one or more weaker binding sites revealed by the tyrosine fluorescence experiment.


View larger version (17K):
[in this window]
[in a new window]
 
Fig. 6.   SDS binding to Bet v 1. Titration of 10 µM Bet v 1 and 10 µM ANS with SDS in 50 mM phosphate, pH 7, 25 °C. Fitting the data to Equation 3, IC50 yields 7.7 ± 0.6 µM. Far-UV CD spectra of Bet v 1 and SDS showed that denaturation commences at ~500 µM SDS (data not shown) changing the mixed alpha /beta spectrum of Bet v 1 to the characteristic all-alpha spectrum. ANS was excited at 350 nm; the emission at 477 nm is displayed. Inset: direct titration of 10 µM Bet v 1 with SDS in 50 mM phosphate, pH 7, 25 °C. Fitting the data to Equation 3, IC50 yields 28.2 ± 8.5 µM. Tyrosine was excited at 278 nm; the emission at 307 nm is displayed.

Identification of Physiologically Relevant Ligands

The ability of native Bet v 1 to form a well-defined fluorescent complex with ANS was utilized to establish an ANS displacement assay, suitable for screening physiologically relevant ligands for binding to Bet v 1. Thus, the binding of non-fluorescent ligands can be indirectly measured as a reduction in ANS fluorescence. Table II provides a summary of the ligands identified and their structures and affinities of interaction with Bet v 1. 

                              
View this table:
[in this window]
[in a new window]
 
Table II
Summary of identified ligands
Overview of the structure and affinity of the identified ligands for Bet v 1.

Interaction with Fatty Acids-- Several studies have suggested a role for fatty acids in pollen-stigma interactions in plants (46, 47). We tested fatty acids with even-numbered chain lengths of 8-22 carbon atoms for binding to Bet v 1. To assess the influence of fatty acid chain conformation, oleic acid was also examined. IC50 values of all fatty acids tested are shown in Fig. 7. The data show that the affinity between fatty acids and Bet v 1 exhibits a parabolic dependence on chain length and is maximal for chain lengths of 14-18 carbon atoms. A lower chain length significantly reduces affinity in a more or less linear fashion. Likewise, chain lengths of more than 20 carbon atoms reduce the affinity dramatically.2 Surprisingly, oleic acid binds with identical affinity compared with stearic acid, i.e. the presence of a cis double bond at position 9 in the chain has no effect on binding.


View larger version (11K):
[in this window]
[in a new window]
 
Fig. 7.   Fatty acid binding to Bet v 1. Affinity of fatty acids for Bet v 1 as a function of chain length. IC50 values were determined from Equation 3 by titrating 10 µM Bet v 1 and 10 µM ANS with fatty acids in 50 mM Tris, pH 7, 25 °C. Error bars represent the standard error of the mean. ANS was excited at 350 nm; the emission at 477 nm is displayed.

Interaction with Flavonoids-- Two plant pigments belonging to the flavonoid group, flavone and 4',5,7-trihydroxyflavone (naringenin), were tested for binding toward Bet v 1. Naringenin has been demonstrated to occur in birch trees (48). ANS displacement curves for flavone and naringenin yield IC50 values of 33.2 ± 4.8 and 28.6 ± 2.3 µM, respectively (data not shown), implying that Bet v 1 binds these compounds with moderate affinity.

Interaction with Cytokinins-- Cytokinins are plant growth hormones that regulate differentiation and proliferation of plant cells. The PR-10 protein from mung bean has been shown to bind cytokinins with high affinity (20); we tested if this is also the case for Bet v 1. Fig. 8 shows the results of a titration of a Bet v 1·ANS complex with N6-(Delta 2-isopentenyl)adenine (IPA), a very potent naturally occurring cytokinin, and N6-furfuryladenine (kinetin), an extremely potent cytokinin. IPA and kinetin bind to Bet v 1 with IC50 values of 64.3 ± 13.6 and 84.1 ± 13.8 µM, respectively, i.e. with lower affinity than the flavonoids and most fatty acids. However, the interaction is very interesting, because the ANS fluorescence increases with increasing ligand concentration. Recording all possible blanks for this experiment (cytokinin alone; ANS and cytokinin; Bet v 1 and cytokinin) reveals that this anomalous ANS behavior is not caused by an intrinsic interaction between cytokinin and ANS or between Bet v 1 and cytokinin (data not shown). The intrinsic fluorescence of Bet v 1 was found to decrease upon binding of kinetin, and a direct binding experiment yielded an IC50 value of 92.4 ± 12.3 µM for kinetin (data not shown). This value is very similar to the one obtained from the indirect assay (84.1 ± 13.8 µM), showing that the presence of ANS does not interfere with binding of kinetin. Thus, the data from the indirect and direct experiments suggest the presence of two separate binding sites, which are non-cooperative. This conclusion was further tested by titrating a saturated Bet v 1·kinetin complex with ANS to investigate whether the affinity of ANS for Bet v 1 is affected by bound kinetin (data not shown). This yields an IC50 value of 37.0 ± 3.7 µM, which is to be compared with a value of 28.8 ± 5.4 µM for ANS. Thus, kinetin has only a marginal effect on the affinity of ANS for Bet v 1 and so corroborates the results of the direct titration.


View larger version (12K):
[in this window]
[in a new window]
 
Fig. 8.   Cytokinin binding to Bet v 1. Titration of 10 µM Bet v 1 and 10 µM ANS with IPA (A) and kinetin (B) in 50 mM phosphate, pH 7, 25 °C. Fitting the data to Equation 3, IC50 yields 64.3 ± 13.6 and 84.1 ± 13.8 µM for IPA and kinetin, respectively. ANS was excited at 350 nm; the emission at 470 nm for IPA and 477 nm for kinetin is displayed.

Interaction with Dehydroergosterol-- Based on the ability of Pru av 1 and the START domain to bind homocastasterone and cholesterol, respectively, a sterol was tested for binding to Bet v 1. We used DHE, a naturally occurring compound, because it is fluorescent and therefore can be utilized in direct binding experiments. Furthermore, it has similar properties to cholesterol (49). Fig. 9 shows the binding curve obtained from a titration of 10 µM DHE with Bet v 1. The fluorescence of DHE is seen to increase upon interaction with Bet v 1 giving rise to a saturable binding profile. Applying Equation 3 to assess the binding affinity yields an IC50 value of 20.9 ± 3.0 µM. To elucidate whether the binding site for DHE overlaps that of cytokinins, we titrated a saturated complex between Bet v 1 and DHE with kinetin. However, we observed no change in DHE fluorescence at kinetin concentrations up to 225 µM, corresponding to more than 2*K<UP><SUB><IT>d</IT></SUB><SUP>kinetin</SUP></UP> (data not shown). This suggests that DHE and kinetin bind to separate parts of Bet v 1. 


View larger version (14K):
[in this window]
[in a new window]
 
Fig. 9.   DHE binding to Bet v 1. Titration of 10 µM DHE with Bet v 1 in 50 mM Tris, pH 7, 25 °C. Fitting the data to Equation 3, IC50 yields 20.9 ± 3.0 µM. DHE was excited at 325 nm; the emission at 374 nm is displayed.

Interaction with Indole-3-acetic Acid, Gibberellic Acid, and Abscisic Acid-- A number of molecules did not show any affinity for Bet v 1, namely the plant hormones indole-3-acetic acid, gibberellic acid, and abscisic acid, as judged from their inability to displace ANS from Bet v 1 or influence the fluorescence of ANS bound to Bet v 1 (data not shown).

    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

The major allergen from birch pollen, Bet v 1, is homologous to the group of PR-10 proteins. PR-10 proteins were originally characterized at the transcriptional level, demonstrating increased gene expression in stress situations, such as during microorganism infection (50). However, only limited functional studies have been performed on the corresponding proteins. It is conceivable, though, that the unusual feature of the Bet v 1 tertiary structure, the internal cavity, plays a central role in the biological function of the molecule and probably does so through specific interaction with an unknown ligand. In this study we have shown that Bet v 1 binds ANS in the native state and have exploited this property of Bet v 1 in an ANS displacement assay to identify a range of physiologically relevant amphiphilic ligands, most of which bind with low micromolar affinity.

Bet v 1·ANS Interaction

Three observations show that Bet v 1 in the native conformation binds ANS: 1) the fluorescence intensity of ANS increases 48-fold at 462 nm upon addition of Bet v 1, 2) lambda max of ANS is concomitantly blue-shifted from ~515 to 474 nm, and 3) the conformational stability of Bet v 1 is augmented in the presence of ANS. Moreover, the binding isotherm is rectangular hyperbolic and reaches saturation suggesting that binding is specific, i.e. a well-defined number of binding sites exist. Indeed, titrating ANS with Bet v 1 at concentrations well above Kd strongly indicates a 1:1 binding stoichiometry. NMR data indicate that binding occurs in the cavity, because Bet v 1 protons perturbed in chemical shift upon addition of ANS are almost exclusively confined to this region. Some degree of dispersion within the cavity is observed, however, which prohibits a more detailed analysis of particular amino acid residues participating in binding. The dispersion of perturbed protons could indicate that ANS binds in different positions in the cavity, creating different Bet v 1·ANS conformers.3 Such conformers must be overlapping, however, to fulfill a stoichiometry of 1:1 binding. Also, ANS fails to induce a CD signal when in complex with Bet v 1 (unlike the dye Congo red, which also binds Bet v 1), suggesting that the environment of ANS in the cavity is not strictly asymmetric (data not shown). A similar distribution of perturbed protons was found from NMR analysis of the homologous protein Pru av 1, the major cherry allergen, mixed with the phytosteroid homocastasterone (21). In this case the perturbed protons surrounded the lower part of the cavity.

Mode of Ligand Binding

Promiscuity in Binding-- Bet v 1 seems promiscuous with respect to ligand binding activity, because it binds compounds differing considerably in size, shape, and hydrophobicity with comparable affinity. For example, Bet v 1 binds myristic, palmitic, and stearic acid with very similar affinities, although these compounds differ by up to four carbon atoms in chain length. Also, the cis double bond in oleic acid, which induces a kink in position nine in the alkyl chain, does not affect the affinity relative to stearic acid. Such broad specificity, however, particularly toward fatty acids, has been found in a number of transport-like proteins, for instance, elicitins, which bind sterols and fatty acids (51), lipid transfer proteins, which bind fatty acids and phospholipids (52), and serum albumins (53). In particular, human serum albumin binds stearic and oleic acid with similar affinities, and crystallographic analysis showed that the cis double bond in oleic acid poses negligible steric hindrance on binding to the different sites on the protein (53).

Cytokinins Bind to an Alternative Site-- The interaction of cytokinins with Bet v 1 is different compared with fatty acids and flavonoids in that the ANS fluorescence increases with increasing cytokinin concentration. In principle, two phenomena can explain this effect: 1) a change in the free energy of association of ANS (i.e. higher affinity so that more ANS molecules are in complex) and 2) a change in probe response (i.e. the quantum yield of ANS is enhanced). The data show that 1) the IC50 values determined from a direct and indirect titration with kinetin are equal within experimental error and 2) the affinity of ANS for Bet v 1 is not significantly affected by bound kinetin. This suggests that Bet v 1 contains two ligand binding sites: one site able to bind ANS but not kinetin and a second site able to bind kinetin but not ANS. The two sites are non-overlapping and non-cooperative, however, kinetin binds in close proximity to ANS and by doing so influences the quantum yield of ANS. Upon titration with kinetin, lambda max of ANS shifts from 477 to 470 nm (data not shown) clearly indicating a decreased polarity of the ANS binding site. Further evidence for the existence of two separate sites comes from the independent binding of DHE and kinetin. Where is the second site then located? It is tempting to suggest that kinetin binds to the P-loop for three reasons: 1) cytokinins are adenine derivatives, and the P-loop is found in many nucleotide binding proteins (3); 2) the affinities of IPA and kinetin are similar suggesting that the adenine moiety is the interacting group; and 3) in Bet v 1 the P-loop forms part of the largest entrance to the cavity allowing the two ligands to bind close to each other. With the present study, two members of the PR-10 family have been shown to bind cytokinins. Primary sequence alignment shows that they share 29% identity and that the P-loop motif also is present in the mung bean protein (20). Unfortunately, no data are available concerning the cytokinin binding site in the mung bean protein. We are currently investigating the binding of various ligands using x-ray crystallography to obtain a more detailed picture of the Bet v 1·ligand interactions.

Relation to Pru av 1 and START-- Direct titration experiments of DHE with Bet v 1 show that Bet v 1 is able to bind sterols with moderate affinity. This conforms to the recent observation that Pru av 1 binds the phytosteroid homocastasterone, although this study provided no quantitative data (21). Modeling studies of Pru av 1 suggested that up to two molecules of sterol could bind in the cavity. Also, binding studies with the fluorescent cholesterol analogue (N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino)-cholesterol (NBD)-cholesterol on StAR, a protein containing a START domain, showed two sterol binding sites (54). The apparent dissociation constant of the Bet v 1·DHE complex (20 µM) may well represent an average of several dissociation constants. However, the Bet v 1·DHE data failed to yield consistent results with binding models employing several binding sites (data not shown). The StAR protein stimulates exchange of DHE between mitochondrial membranes in vitro (54). DHE exchange experiments (55) reveal no such activity for Bet v 1 in small unilamellar vesicles (data not shown) indicating that Bet v 1 is not a sterol carrier protein but rather a sterol binding protein.

Implications of the Identified Ligands on the Biological Function of Bet v 1

The sequence similarity and wide distribution of the PR-10 proteins throughout the plant kingdom is an indication of an indispensable function in plants. It is, however, difficult to assign a unique function to all PR-10 members, because no coordinated expression occurs. In birch, for example, Bet v 1 is expressed from several loci. Certain isoforms are constitutively expressed in roots (56) or in pollen. Others are only expressed upon infection with fungi or bacteria (57, 58) or upon copper stress (59). This study points to ligand binding activity as an important aspect of the biological function of Bet v 1. The multiplicity of ligands identified, however, hampers the assignment of a unique function. The Bet v 1 isoform used in this study is expressed in pollen, and the following discussion is therefore restricted to pollen physiology.

The processes leading to plant reproduction, i.e. germination of the pollen grain on the stigma, directional pollen tube growth, and fertilization, involve a myriad of cell-cell recognition and signaling events (60). The fact that Bet v 1 is present in large quantities in the pollen grain and readily extracted upon hydration (61) suggests that Bet v 1 is involved in these processes. The majority of ligands that have been identified in this study, fatty acids, flavonoids, and cytokinins, theoretically could be involved in such processes. Lipids are important for hydration of the pollen grain (62). They are thought to form a watertight seal between pollen and stigma, facilitating the rapid transport of water into pollen through channels in the stigma and pollen membranes. In petunia, the flavonoid kaempferol is required for pollen fertility (63). The enzyme chalcone synthase catalyzes the first step in the biosynthesis of flavonoids, and chalcone synthase-deficient petunia cannot form the pollen tube (63). In this study we have shown that Bet v 1 binds flavone and naringenin, compounds very similar to kaempferol. The ability of Bet v 1 to bind long-chain fatty acids and flavonoids may suggest a role for Bet v 1 in ensuring proper hydration and germination of pollen, for instance by transporting the lipids or flavonoids to the stigmatic surface and releasing them there.

Cytokinins are plant growth hormones that control differentiation and proliferation of plant cells. Certain proteins have evolved to bind these hormones, however, their specific function has not been established (64). It has been suggested that cytokinin binding proteins may act as storage compartments for cytokinins in seeds allowing rapid release of cytokinins upon germination (64). This could be compatible with a role for Bet v 1 in cytokinin binding.

In addition, it could be speculated that Bet v 1 plays a role in plants similar to that of serum albumin in animals. Serum albumin is a general transporter of endogenous ligands such as non-esterified fatty acids, bilirubin, and thyroxine (65). It binds fatty acids in an asymmetric fashion (66) with dissociation constants from low nanomolar to low micromolar concentrations (67). Another protein to bind a wide range of ligands with similar affinities without strict complementarity is adipocyte lipid binding protein. The binding affinity is in the nanomolar range according to ANS displacement assays (68, 69).

Several of the PR-10 proteins have been proposed to possess RNase activity (22-25), which may constitute a common trait of this protein family (50). The present study clearly demonstrates that Bet v 1 is capable of binding several types of ligands, most of which bind in the cavity suggesting a transport or storage function of Bet v 1, a role that is difficult to reconcile with RNase activity. It is generally accepted that plant RNases utilize two surface-exposed histidines for catalytic activity (70). Bet v 1 has no such residues in a similar spatial arrangement. Also, a naturally occurring RNase-like protein from resting rhizomes of Hedge bindweed (Calystegia sepium) lacking one of these particular histidine residues is inactive (70).

In conclusion, this study demonstrates that Bet v 1 binds a variety of different small amphiphilic compounds with moderate to high affinity. Many of the ligands identified occur naturally in plants, and therefore the identification of these compounds as ligands for Bet v 1 suggests that ligand binding activity is important for the biological function of this protein.

    ACKNOWLEDGEMENTS

We thank Karen G. Welinder and Klaus D. Grasser for valuable discussions of the manuscript and Laurent Duroux and Henrik Ipsen for suggesting relevant ligands to be tested.

    FOOTNOTES

* The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

To whom correspondence should be addressed. Tel.: 45-9635-8525; Fax: 45-9814-1808; E-mail: dao@bio.auc.dk.

Published, JBC Papers in Press, April 12, 2002, DOI 10.1074/jbc.M202065200

2 We can disregard complications with micelle formation for fatty acids with chain lengths up to 20 carbon atoms, because their Cmc values are well above the apparent Kd (71). C22 fatty acid has a Cmc value of around 10 µM, which may, however, interfere with our measurements. If so, the effect will be a slight underestimation of the apparent Kd.

3 The cavity of Bet v 1 is 30 Å long and has a volume of approximately 1500 Å3 (3) indicating that the volume of the cavity is relatively large compared to the size of ANS.

    ABBREVIATIONS

The abbreviations used are: Bet v 1, major allergen from birch tree pollen; 2QF-COSY, double-quantum-filtered correlation spectroscopy; ANS, 8-anilino-1-naphthalenesulfonic acid; Cmc, critical micelle concentration; DHE, dehydroergosterol; IC50, apparent dissociation constant; IPA, N6-(Delta 2-isopentenyl)adenine; NOE, nuclear Overhauser effect; NOESY, nuclear Overhauser enhancement spectroscopy; PR-10 protein, pathogenesis-related protein, subfamily 10; Pru av 1, major allergen from cherry; START domain, steroidogenic acute regulatory-related lipid transfer domain; CD, circular dichroism; MES, 4-morpholineethanesulfonic acid; MOPS, 4-morpholinepropanesulfonic acid; bis-ANS, 4,4'-dianilino-1,1'-binaphthyl-5,5'-disulfonic acid.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Larsen, J. N. (1995) ACI News 7, 141-146, 160
2. Gajhede, M., Osmark, P., Poulsen, F. M., Ipsen, H., Larsen, J. N., van Neerven, R. J. J., Schou, C., Løwenstein, H., and Spangfort, M. D. (1996) Nat. Struct. Biol. 3, 1040-1045[CrossRef][Medline] [Order article via Infotrieve]
3. Saraste, M., Sibbald, P. R., and Wittinghofer, A. (1990) Trends Biochem. Sci. 15, 430-434[CrossRef][Medline] [Order article via Infotrieve]
4. Ipsen, H., and Løwenstein, H. (1983) J. Allergy Clin. Immunol. 72, 150-159[CrossRef][Medline] [Order article via Infotrieve]
5. Vrtala, S., Hirtenlehner, K., Susani, M., Akdis, M., Kussebi, F., Akdis, C. A., Blaser, K., Hufnagl, P., Binder, B. R., Politou, A., Pastore, A., Vangelista, L., Sperr, W. R., Semper, H., Valent, P., Ebner, C., Kraft, D., and Valenta, R. (2001) FASEB J. 15, 2045-2047[Abstract/Free Full Text]
6. van Loon, L. C., and van Strien, E. A. (1999) Physiol. Mol. Plant Pathol. 55, 85-97[CrossRef]
7. Breiteneder, H., and Ebner, C. (2000) J. Allergy Clin. Immunol 106, 27-36[CrossRef][Medline] [Order article via Infotrieve]
8. Breiteneder, H., Ferreira, F., Reikerstorfer, A., Duchene, M., Valenta, R., Hoffmann-Sommergruber, K., Ebner, C., Breitenbach, M., Kraft, D., and Scheiner, O. (1992) J. Allergy Clin. Immunol. 90, 909-917[CrossRef][Medline] [Order article via Infotrieve]
9. Larsen, J. N., Strøman, P., and Ipsen, H. (1992) Mol. Immunol. 29, 703-711[CrossRef][Medline] [Order article via Infotrieve]
10. Breiteneder, H., Ferreira, F., Hoffmann-Sommergruber, K., Ebner, C., Breitenbach, M., Rumpold, H., Kraft, D., and Scheiner, O. (1993) Eur. J. Biochem. 212, 355-362[Medline] [Order article via Infotrieve]
11. Vanek-Krebitz, M., Hoffmann-Sommergruber, K., Laimer da Camara Machado, M., Susani, M., Ebner, C., Kraft, D., Scheiner, O., and Breiteneder, H. (1995) Biochem. Biophys. Res. Commun. 214, 538-551[CrossRef][Medline] [Order article via Infotrieve]
12. Scheurer, S., Metzner, K., Haustein, D., and Vieths, S. (1997) Mol. Immunol. 34, 619-629[CrossRef][Medline] [Order article via Infotrieve]
13. Hoffmann-Sommergruber, K., Ferris, R., Pec, M., Radauer, C., O'Riordain, G., Laimer da Camara Machado, M., Scheiner, O., and Breiteneder, H. (2000) Int. Arch. Allergy Immunol. 122, 115-123[CrossRef][Medline] [Order article via Infotrieve]
14. Ortolani, C., Ispano, M., Pastorello, E., Bigi, A., and Ansaloni, R. (1988) Ann. Allergy 61, 47-52[Medline] [Order article via Infotrieve]
15. Osmark, P., Boyle, B., and Brisson, N. (1998) Plant Mol. Biol. 38, 1243-1246[CrossRef][Medline] [Order article via Infotrieve]
16. Nessler, C. L., and Vonder Haar, R. A. (1990) Planta 180, 487-491
17. Pozueta-Romero, J., Klein, M., Houlne, G., Schantz, M. L., Meyer, B., and Schantz, R. (1995) Plant Mol. Biol. 28, 1011-1025[CrossRef][Medline] [Order article via Infotrieve]
18. Tsujishita, Y., and Hurley, J. H. (2000) Nat. Struct. Biol. 7, 408-414[CrossRef][Medline] [Order article via Infotrieve]
19. Watari, H., Arakane, F., Moog-Lutz, C., Kallen, C. B., Tomasetto, C., Gerton, G. L., Rio, M.-C., Baker, M. E., and Strauss, J. F., III (1997) Proc. Natl. Acad. Sci. U. S. A. 94, 8462-8467[Abstract/Free Full Text]
20. Fujimoto, Y., Nagata, R., Fukasawa, H., Yano, K., Azuma, M., Iida, A., Sugimoto, S., Shudo, K., and Hashimoto, Y. (1998) Eur. J. Biochem. 258, 794-802[Medline] [Order article via Infotrieve]
21. Neudecker, P., Schweimer, K., Nerkamp, J., Scheurer, S., Vieths, S., Sticht, H., and Rösch, P. (2001) J. Biol. Chem. 276, 22756-22763[Abstract/Free Full Text]
22. Moiseyev, G. P., Fedoreyeva, L. I., Zhuravlev, Y. N., Yasnetskaya, E., Jekel, P. A., and Beintema, J. J. (1997) FEBS Lett. 407, 207-210[CrossRef][Medline] [Order article via Infotrieve]
23. Bantignies, B., Séguin, J., Muzac, I., Dédaldéchamp, F., Gulick, P., and Ibrahim, R. (2000) Plant Mol. Biol. 42, 871-881[CrossRef][Medline] [Order article via Infotrieve]
24. Bufe, A., Spangfort, M. D., Kahlert, H., Schlaak, M., and Becker, W.-M. (1996) Planta 199, 413-415[CrossRef][Medline] [Order article via Infotrieve]
25. Swoboda, I., Hoffmann-Sommergruber, K., O'Riordain, G., Scheiner, O., Heberle-Bors, E., and Vicente, O. (1996) Physiol. Plant. 96, 433-438[CrossRef]
26. Iyer, L. M., Koonin, E. V., and Aravind, L. (2001) Proteins 43, 134-144[CrossRef][Medline] [Order article via Infotrieve]
27. Spangfort, M. D., Ipsen, H., Sparholt, S. H., Aasmul-Olsen, S., Larsen, M. R., Mørtz, E., Roepstorff, P., and Larsen, J. N. (1996) Protein Expr. Purif. 8, 365-373[CrossRef][Medline] [Order article via Infotrieve]
28. Gill, S. C., and von Hippel, P. H. (1989) Anal. Biochem. 182, 319-326[CrossRef][Medline] [Order article via Infotrieve]
29. Kirk, W. R., Kurian, E., and Prendergast, F. G. (1996) Biophys. J. 79, 69-83
30. Marion, D., Ikura, M., Tschudin, R., and Bax, A. (1989) J. Magn. Reson. 85, 393-399
31. Piotto, M., Saudek, V., and Sklenár, V. (1992) J. Biomol. NMR 2, 661-665[CrossRef][Medline] [Order article via Infotrieve]
32. Bartels, C., Xia, T., Billeter, M., Güntert, P., and Wüthrich, K. (1995) J. Biomol. NMR 5, 1-10[CrossRef][Medline] [Order article via Infotrieve]
33. Schweimer, K., Sticht, H., Nerkamp, J., Boehm, M., Breitenbach, M., Vieths, S., and Rösch, P. (1999) Appl. Magn. Reson. 17, 449-464
34. Osmark, P. (1996) Structure and Function of Bet v 1, the Major Allergen from Birch Pollen, and Its Homologues.Ph.D. thesis , University of Copenhagen, Copenhagen
35. Wimmer, R., Müller, N., and Petersen, S. B. (1997) J. Biomol. NMR 9, 101-104[CrossRef][Medline] [Order article via Infotrieve]
36. Stryer, L. (1965) J. Mol. Biol. 13, 482-495[Medline] [Order article via Infotrieve]
37. Wassenberg, J. J., Reed, R. C., and Nicchitta, C. V. (2000) J. Biol. Chem. 275, 22806-22814[Abstract/Free Full Text]
38. Cheng, Y., and Prusoff, W. H. (1973) Biochem. Pharmacol. 22, 3099-3108[CrossRef][Medline] [Order article via Infotrieve]
39. Smutzer, G., Crawford, B. F., and Yeagle, P. L. (1986) Biochim. Biophys. Acta 862, 361-371[Medline] [Order article via Infotrieve]
40. Engelhard, M., and Evans, P. A. (1995) Protein Sci. 4, 1553-1562[Medline] [Order article via Infotrieve]
41. Schönbrunn, E., Eschenburg, S., Luger, K., Kabsch, W., and Armhein, N. (2000) Proc. Natl. Acad. Sci. U. S. A. 97, 6345-6349[Abstract/Free Full Text]
42. Ory, J. J., and Banaszak, L. J. (1999) Biophys. J. 77, 1107-1116[Medline] [Order article via Infotrieve]
43. Slavik, J. (1982) Biochim. Biophys. Acta 694, 1-25[Medline] [Order article via Infotrieve]
44. Rosen, C.-G., and Weber, G. (1969) Biochemistry 8, 3915-3920[CrossRef][Medline] [Order article via Infotrieve]
45. Vanderheeren, G., Hanssens, I., Noyelle, K., Van Dael, H., and Joniau, M. (1998) Biophys. J. 75, 2195-2204[Medline] [Order article via Infotrieve]
46. Preuss, D., Lemeieux, B., Yen, G., and Davis, R. W. (1993) Genes Dev. 7, 974-985[Abstract/Free Full Text]
47. Wolters-Arts, M., Lush, W. M., and Mariani, C. (1998) Nature 392, 818-821[CrossRef][Medline] [Order article via Infotrieve]
48. Ossipov, V., Nurmi, K., Loponen, J., Prokopiev, N., Haukioja, E., and Pihlaja, K. (1995) Biochem. Syst. Ecol. 23, 213-222[CrossRef]
49. Schroeder, F., Jefferson, J. R., Kier, A. B., Knittel, J., Scallen, T. J., and Wood Hapala, I. (1991) Proc. Soc. Exp. Biol. Med. 196, 235-252[CrossRef][Medline] [Order article via Infotrieve]
50. van Loon, L. C., Pierpoint, W. S., Boller, T., and Conejero, V. (1994) Plant Mol. Biol. Rep. 12, 245-264[CrossRef]
51. Osman, H., Mikes, V., Milat, M. L., Ponchet, M., Marion, D., Prange, T., Maume, B. F., Vauthrin, S., and Blein, J. P. (2001) FEBS Lett. 489, 55-58[CrossRef][Medline] [Order article via Infotrieve]
52. Garcia-Olmedo, F., Molina, A., Segura, A., and Moreno, M. (1995) Trends Microbiol. 3, 72-74[CrossRef][Medline] [Order article via Infotrieve]
53. Petitpas, I., Grune, T., Bhattacharya, A. A., and Curry, S. (2001) J. Mol. Biol. 314, 955-960[CrossRef][Medline] [Order article via Infotrieve]
54. Petrescu, A. D., Gallegos, A. M., Okamura, Y., Strauss, J. F., 3rd, and Schroeder, F. (2001) J. Biol. Chem. 276, 36970-36982[Abstract/Free Full Text]
55. Schroeder, F., Butko, P., Hapala, I., and Scallen, T. J. (1990) Lipids 25, 669-674[CrossRef][Medline] [Order article via Infotrieve]
56. Poupard, P., Brunel, N., Leduc, N., Viémont, J.-D., Strullu, D.-G., and Simoneau, P. (2001) Aust. J. Plant. Physiol. 28, 57-63
57. Swoboda, I., Scheiner, O., Heberle-Bors, E., and Vicente, O. (1995) Plant Cell Environ. 18, 865-874[CrossRef]
58. Swoboda, I., Scheiner, O., Kraft, D., Breitenbach, M., Heberle-Bors, E., and Vicente, O. (1994) Biochim. Biophys. Acta 1219, 457-464[Medline] [Order article via Infotrieve]
59. Utriainen, M., Kokko, H., Auriola, S., Sarrazin, O., and Kärenlampi, S. (1998) Plant Cell Environ. 21, 821-828[CrossRef]
60. Franklin-Tong, V. E. (1999) Plant Cell 11, 727-738[Free Full Text]
61. Vrtala, S., Grote, M., Duchene, M., van Ree, R., Kraft, D., Scheiner, O., and Valenta, R. (1993) Int. Arch. Allergy Immunol. 102, 160-169[CrossRef][Medline] [Order article via Infotrieve]
62. Wilhelmi, L. K., and Preuss, D. (1999) Curr. Opin. Plant Biol. 2, 18-22[CrossRef][Medline] [Order article via Infotrieve]
63. Mo, Y., Nagel, C., and Tayler, L. P. (1992) Proc. Natl. Acad. Sci. U. S. A. 89, 7213-7217[Abstract/Free Full Text]
64. Kobayashi, K., Fukuda, M., Igarashi, D., and Sunaoshi, M. (2000) Plant Cell Physiol. 41, 148-157[Medline] [Order article via Infotrieve]
65. Peters, T. (1995) All About Albumin: Biochemistry, Genetics and Medical Applications , Academic Press, San Diego
66. Curry, S., Mandelkow, H., Brick, P., and Franks, N. (1998) Nat. Struct. Biol. 5, 827-835[CrossRef][Medline] [Order article via Infotrieve]
67. Richieri, G. V., Anel, A., and Kleinfeld, A. M. (1993) Biochemistry 32, 7574-7580[CrossRef][Medline] [Order article via Infotrieve]
68. Richieri, G. V., Ogata, R. T., and Kelinfeld, A. M. (1996) J. Biol. Chem. 271, 31068-31074[Abstract/Free Full Text]
69. Kane, C. D., and Bernlohr, D. A. (1996) Anal. Biochem. 233, 197-204[CrossRef][Medline] [Order article via Infotrieve]
70. Van Damme, E. J., Hao, Q., Barre, A., Rouge, P., Van Leuven, F., and Peumans, W. J. (2000) Plant Physiol. 122, 433-446[Abstract/Free Full Text]
71. Kreshech, G. C. (1975) in Surfactants in Water: A Comprehensive Treatise (Franks, F., ed) , pp. 95-167, Plenum Press, New York


Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Plant Physiol.Home page
P. Zubini, B. Zambelli, F. Musiani, S. Ciurli, P. Bertolini, and E. Baraldi
The RNA Hydrolysis and the Cytokinin Binding Activities of PR-10 Proteins Are Differently Performed by Two Isoforms of the Pru p 1 Peach Major Allergen and Are Possibly Functionally Related
Plant Physiology, July 1, 2009; 150(3): 1235 - 1247.
[Abstract] [Full Text] [PDF]


Home page
Plant Physiol.Home page
S. Depuydt, S. Trenkamp, A. R. Fernie, S. Elftieh, J.-P. Renou, M. Vuylsteke, M. Holsters, and D. Vereecke
An Integrated Genomics Approach to Define Niche Establishment by Rhodococcus fascians
Plant Physiology, March 1, 2009; 149(3): 1366 - 1386.
[Abstract] [Full Text] [PDF]


Home page
Plant Physiol.Home page
G. E. van Noorden, T. Kerim, N. Goffard, R. Wiblin, F. I. Pellerone, B. G. Rolfe, and U. Mathesius
Overlap of Proteome Changes in Medicago truncatula in Response to Auxin and Sinorhizobium meliloti
Plant Physiology, June 1, 2007; 144(2): 1115 - 1131.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H.-L. Liou, S. S. Dixit, S. Xu, G. S. Tint, A. M. Stock, and P. Lobel
NPC2, the Protein Deficient in Niemann-Pick C2 Disease, Consists of Multiple Glycoforms That Bind a Variety of Sterols
J. Biol. Chem., December 1, 2006; 281(48): 36710 - 36723.
[Abstract] [Full Text] [PDF]


Home page
Plant CellHome page
O. Pasternak, G. D. Bujacz, Y. Fujimoto, Y. Hashimoto, F. Jelen, J. Otlewski, M. M. Sikorski, and M. Jaskolski
Crystal Structure of Vigna radiata Cytokinin-Specific Binding Protein in Complex with Zeatin
PLANT CELL, October 1, 2006; 18(10): 2622 - 2634.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
M. Mancek-Keber and R. Jerala
Structural similarity between the hydrophobic fluorescent probe and lipid A as a ligand of MD-2
FASEB J, September 1, 2006; 20(11): 1836 - 1842.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. P. Bais, R. Vepachedu, C. B. Lawrence, F. R. Stermitz, and J. M. Vivanco
Molecular and Biochemical Characterization of an Enzyme Responsible for the Formation of Hypericin in St. John's Wort (Hypericum perforatum L.)
J. Biol. Chem., August 22, 2003; 278(34): 32413 - 32422.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
277/26/23684    most recent
M202065200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mogensen, J. E.
Right arrow Articles by Otzen, D. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mogensen, J. E.
Right arrow Articles by Otzen, D. E.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement